Firefly Neuroscience, Inc. AIFF
1.04 USD +0.06 (+6.12%)
At closeNov 4, 2026, 4:22 PM EST
1.00 -0.04 -3.73%
After hours · Nov 4, 4:22 PM ET
0.9873 Day range 1.04
0.62 52-week range 3.15
- YTD
- +18.18%
- 1 year
- -37.72%
Financial health
Altman Z-Score
-6.09 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
Valuation
P/E -0.5×
FY 2020 5y median -15.4× FY 2025
P/S 10.1×
FY 2020 5y median 80.1× FY 2025
P/B 1.5×
FY 2020 5y median -46.3× FY 2025
P/FCF -1.4×
FY 2020 5y median -15.6× FY 2025
EV/EBITDA -0.5×
FY 2020 5y median -14.6× FY 2025
EV/Sales 7.7×
FY 2020 5y median 75.8× FY 2025
FCF Yield -72.1%
FY 2020 5y median -6.4% FY 2025
Profitability
Gross Margin 56.5%
FY 2020 5y median 56.5% FY 2025
Operating Margin -753.5%
FY 2020 5y median -753.5% FY 2025
Net Margin -1741.0%
FY 2020 5y median -1741.0% FY 2025
ROE -260.3%
FY 2020 5y median 145.4% FY 2025
ROIC -112.4%
FY 2020 5y median -112.4% FY 2025
ROA -189.8%
FY 2020 5y median -227.3% FY 2025
Growth (YoY)
Revenue 957.4%
FY 2020 FY 2025
Operating Income 6.3%
FY 2020 FY 2025
EPS (diluted) -13.7%
FY 2020 FY 2025
Free Cash Flow -26.7%
FY 2020 FY 2025
Financial Health
Current Ratio 1.4×
FY 2020 5y median 0.5× FY 2025
Quick Ratio 1.4×
FY 2020 5y median 0.5× FY 2025
Debt / Equity 0.0×
FY 2020 5y median 0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2020 5y median 0.1× FY 2025
Interest Coverage -54.1×
FY 2020 5y median -54.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31